{"id":"heparin-prophylactic-dosage","safety":{"commonSideEffects":[{"rate":"1-5","effect":"Bleeding"},{"rate":"0.5-3","effect":"Heparin-induced thrombocytopenia (HIT)"},{"rate":"null","effect":"Injection site reactions"},{"rate":"null","effect":"Osteoporosis (with long-term use)"}]},"_chembl":{"chemblId":"CHEMBL4650299","moleculeType":"Oligosaccharide"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Heparin is an anticoagulant that works by binding to and enhancing the activity of antithrombin III, a natural inhibitor of blood coagulation. This complex inactivates several clotting factors (particularly factors IIa and Xa), preventing the formation of fibrin clots. At prophylactic doses, heparin reduces the risk of thromboembolism without causing significant bleeding in most patients.","oneSentence":"Heparin inhibits blood coagulation by potentiating antithrombin III, which inactivates thrombin and other clotting factors to prevent clot formation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:47:41.438Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prophylaxis of venous thromboembolism in surgical patients"},{"name":"Prophylaxis of deep vein thrombosis and pulmonary embolism in medical patients"}]},"trialDetails":[{"nctId":"NCT06753786","phase":"NA","title":"Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage","status":"RECRUITING","sponsor":"Pirogov Russian National Research Medical University","startDate":"2024-10-21","conditions":"Venous Thromboembolism, Pulmonary Embolism, Intracerebral Hemorrhage","enrollment":200},{"nctId":"NCT07299695","phase":"PHASE3","title":"Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Argyrios Tzouvelekis","startDate":"2026-01-25","conditions":"Idiopathic Pulmonary Fibrosis, Acute Exacerbation of Idiopathic Pulmonary Fibrosis","enrollment":196},{"nctId":"NCT07388056","phase":"","title":"Efficacy and Safety of Extended Anticoagulant Therapy in Cancer Associated Thrombosis in Thai Population","status":"COMPLETED","sponsor":"Thammasat University","startDate":"2012-01-01","conditions":"Cancer-associated Thrombosis","enrollment":169},{"nctId":"NCT06243510","phase":"NA","title":"Comparison of Apixaban Versus Enoxaparin","status":"ENROLLING_BY_INVITATION","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2023-11-24","conditions":"Bladder Cancer","enrollment":90},{"nctId":"NCT06381661","phase":"PHASE2","title":"Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-05-01","conditions":"Sepsis","enrollment":2000},{"nctId":"NCT06195540","phase":"PHASE3","title":"RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing","status":"RECRUITING","sponsor":"University Hospital, Angers","startDate":"2024-07-19","conditions":"Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism","enrollment":1424},{"nctId":"NCT05625932","phase":"PHASE3","title":"TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer","status":"COMPLETED","sponsor":"Galician Research Group on Digestive Tumors","startDate":"2023-03-02","conditions":"Colorectal Cancer Metastatic, Thromboembolism","enrollment":232},{"nctId":"NCT04924322","phase":"PHASE2, PHASE3","title":"Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies","status":"RECRUITING","sponsor":"Yale University","startDate":"2022-05-11","conditions":"Deep Venous Thrombosis","enrollment":258},{"nctId":"NCT06845423","phase":"PHASE4","title":"Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk","status":"RECRUITING","sponsor":"University Hospital, Brest","startDate":"2025-05-16","conditions":"Venous Thromboembolism (VTE), Post Partum Women","enrollment":2400},{"nctId":"NCT05735639","phase":"PHASE4","title":"THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2024-01-22","conditions":"Venous Thromboembolism, Varicose Veins","enrollment":6660},{"nctId":"NCT05058924","phase":"NA","title":"Low Molecular Weight hEparin vs. Aspirin Post-partum","status":"COMPLETED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2021-08-29","conditions":"Venous Thromboembolism","enrollment":30},{"nctId":"NCT04507178","phase":"PHASE2","title":"Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2022-02-02","conditions":"Aneurysmal Subarachnoid Hemorrhage, Delayed Cerebral Ischemia","enrollment":100},{"nctId":"NCT04710732","phase":"PHASE4","title":"Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test.","status":"TERMINATED","sponsor":"Pirogov Russian National Research Medical University","startDate":"2021-03-01","conditions":"Venous Thromboembolism","enrollment":9},{"nctId":"NCT04505774","phase":"PHASE4","title":"Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE","status":"COMPLETED","sponsor":"Matthew Neal MD","startDate":"2020-09-04","conditions":"Covid19","enrollment":3591},{"nctId":"NCT04367831","phase":"PHASE4","title":"Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19","status":"COMPLETED","sponsor":"Columbia University","startDate":"2020-05-02","conditions":"COVID-19, Venous Thromboses, Arterial Thrombosis","enrollment":94},{"nctId":"NCT03559114","phase":"PHASE3","title":"PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2018-07-19","conditions":"Traumatic Brain Injury","enrollment":1100},{"nctId":"NCT06583330","phase":"NA","title":"A Multicenter, Open-Label, Non-Inferiority Randomized Controlled Trial of Postoperative VTE Prevention in Chinese Patients After Colorectal Cancer Surgery","status":"NOT_YET_RECRUITING","sponsor":"Beijing Friendship Hospital","startDate":"2024-10","conditions":"Colorectal Surgery, VTE (Venous Thromboembolism)","enrollment":1448},{"nctId":"NCT06259149","phase":"","title":"A Study of Initiation Timing of VTE Prevention After Colorectal Cancer Surgery","status":"RECRUITING","sponsor":"RenJi Hospital","startDate":"2024-02-01","conditions":"Colorectal Cancer","enrollment":914},{"nctId":"NCT06513481","phase":"","title":"A Study of Enhancing Drug Prophylaxis of Venous Thromboembolism in Chinese Colorectal Cancer Surgery","status":"NOT_YET_RECRUITING","sponsor":"RenJi Hospital","startDate":"2024-07-16","conditions":"Colorectal Cancer","enrollment":914},{"nctId":"NCT05540834","phase":"PHASE2","title":"Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure","status":"RECRUITING","sponsor":"South West Sydney Local Health District","startDate":"2022-05-18","conditions":"Acute Respiratory Failure, Hypercoagulability, Fibrinolysis Shutdown","enrollment":70},{"nctId":"NCT03659708","phase":"NA","title":"Pregnancy and Risk of Venous Thromboembolism","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2021-01-22","conditions":"Thromboembolism, Pregnancy","enrollment":600},{"nctId":"NCT02580773","phase":"PHASE3","title":"Therapeutic Anticoagulation Strategy for Acute Chest Syndrome","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-12-16","conditions":"Anemia, Sickle Cell, Acute Chest Syndrome","enrollment":198},{"nctId":"NCT04409834","phase":"PHASE4","title":"Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial","status":"COMPLETED","sponsor":"The TIMI Study Group","startDate":"2020-08-05","conditions":"COVID-19, Venous Thromboembolism, Arterial Thrombosis","enrollment":390},{"nctId":"NCT04406389","phase":"PHASE4","title":"Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial)","status":"TERMINATED","sponsor":"Weill Medical College of Cornell University","startDate":"2020-10-13","conditions":"COVID-19","enrollment":14},{"nctId":"NCT04373707","phase":"PHASE4","title":"Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19","status":"COMPLETED","sponsor":"Central Hospital, Nancy, France","startDate":"2020-05-13","conditions":"COVID, Thrombosis, Pulmonary Embolism","enrollment":1000},{"nctId":"NCT04646655","phase":"PHASE3","title":"Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19","status":"COMPLETED","sponsor":"ASST Fatebenefratelli Sacco","startDate":"2020-07-27","conditions":"Covid19, Thrombosis","enrollment":142},{"nctId":"NCT04305106","phase":"PHASE3","title":"Bevacizumab in Patients With Severe Covid-19","status":"UNKNOWN","sponsor":"Qilu Hospital of Shandong University","startDate":"2023-01-12","conditions":"COVID-19 Pneumonia","enrollment":588},{"nctId":"NCT05878899","phase":"PHASE3","title":"Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled Trial","status":"COMPLETED","sponsor":"University Hospital, Geneva","startDate":"2022-05-03","conditions":"Venous Thromboembolism","enrollment":77},{"nctId":"NCT04542408","phase":"PHASE3","title":"Hamburg Edoxaban for Anticoagulation in COVID-19 Study","status":"COMPLETED","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2020-11-12","conditions":"Covid19","enrollment":140},{"nctId":"NCT05224388","phase":"","title":"Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2020-01-01","conditions":"COVID-19, Deep Vein Thrombosis, Anticoagulants and Bleeding Disorders","enrollment":813},{"nctId":"NCT02590601","phase":"PHASE3","title":"Bromocriptine in the Treatment of Peripartum Cardiomyopathy","status":"WITHDRAWN","sponsor":"Montreal Heart Institute","startDate":"2017-01-01","conditions":"Peripartum Cardiomyopathy","enrollment":""},{"nctId":"NCT04512079","phase":"PHASE4","title":"FREEDOM COVID-19 Anticoagulation Strategy","status":"COMPLETED","sponsor":"Valentin Fuster","startDate":"2020-09-08","conditions":"COVID-19, SARS-CoV-2","enrollment":3460},{"nctId":"NCT04655586","phase":"PHASE2, PHASE3","title":"Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19","status":"COMPLETED","sponsor":"ARCA Biopharma, Inc.","startDate":"2020-12-10","conditions":"Covid19","enrollment":160},{"nctId":"NCT04569279","phase":"PHASE3","title":"Rivaroxaban vs. Warfarin in CVT Treatment","status":"COMPLETED","sponsor":"Damascus University","startDate":"2017-09-01","conditions":"Cerebral Vein Thrombosis","enrollment":71},{"nctId":"NCT02856295","phase":"PHASE4","title":"anti10a Levels in Women Treated With LMWH in the Postpartum Period","status":"COMPLETED","sponsor":"HaEmek Medical Center, Israel","startDate":"2021-11-20","conditions":"Venous Thromboembolism","enrollment":136},{"nctId":"NCT04730856","phase":"NA","title":"Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID)","status":"COMPLETED","sponsor":"Hospital Universitario Infanta Leonor","startDate":"2021-02-01","conditions":"Covid19, Thrombosis","enrollment":311},{"nctId":"NCT04808882","phase":"PHASE2","title":"ANTIcoagulation in Severe COVID-19 Patients","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-04-14","conditions":"Severe COVID-19 Pneumonia","enrollment":353},{"nctId":"NCT04736901","phase":"","title":"Effect of Prophylactic and Therapeutic Anticoagulants in Egyptian Patients With COVID-19","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2020-12-01","conditions":"Covid19, Corona Virus Infection, Hypercoagulability","enrollment":90},{"nctId":"NCT04492254","phase":"PHASE3","title":"Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients","status":"TERMINATED","sponsor":"Thrombosis Research Institute","startDate":"2020-10-27","conditions":"COVID-19","enrollment":219},{"nctId":"NCT04623177","phase":"","title":"Thromboprophylaxis for Patients in ICU With COVID-19","status":"COMPLETED","sponsor":"Instituto de Investigacion Sanitaria La Fe","startDate":"2020-03-01","conditions":"Covid19, Anticoagulant Therapy, Thrombosis","enrollment":822},{"nctId":"NCT04394182","phase":"NA","title":"Ultra Low Doses of Therapy With Radiation Applicated to COVID-19","status":"SUSPENDED","sponsor":"Fundacion GenesisCare","startDate":"2020-04-21","conditions":"Pneumonia, Viral, Cytokine Storm","enrollment":15},{"nctId":"NCT04600141","phase":"PHASE3","title":"Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2020-11-10","conditions":"Covid19","enrollment":308},{"nctId":"NCT04305756","phase":"NA","title":"Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-06-12","conditions":"Thromboembolism, Postpartum DVT, Thrombosis","enrollment":146},{"nctId":"NCT04401293","phase":"PHASE3","title":"Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients","status":"COMPLETED","sponsor":"Northwell Health","startDate":"2020-04-26","conditions":"Sars-CoV2, COVID","enrollment":257},{"nctId":"NCT04345848","phase":"PHASE3","title":"Preventing COVID-19 Complications With Low- and High-dose Anticoagulation","status":"TERMINATED","sponsor":"University Hospital, Geneva","startDate":"2020-04-28","conditions":"COVID, Sars-CoV2","enrollment":160},{"nctId":"NCT04486508","phase":"PHASE3","title":"Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19","status":"COMPLETED","sponsor":"Rajaie Cardiovascular Medical and Research Center","startDate":"2020-07-30","conditions":"Covid19","enrollment":600},{"nctId":"NCT04485429","phase":"PHASE3","title":"Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia","status":"WITHDRAWN","sponsor":"D'Or Institute for Research and Education","startDate":"2020-07-20","conditions":"COVID-19","enrollment":""},{"nctId":"NCT04528888","phase":"PHASE3","title":"Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection","status":"UNKNOWN","sponsor":"Massimo Girardis","startDate":"2020-11-25","conditions":"Covid19, SARS-CoV Infection, Pneumonia, Viral","enrollment":210},{"nctId":"NCT02600260","phase":"NA","title":"Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2014-12-01","conditions":"Thrombophilia Associated With Pregnancy, Perioperative/Postoperative Complications, Venous Thrombosis","enrollment":7212},{"nctId":"NCT04829552","phase":"","title":"Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19 Infection at the Time of Admission To Critical Care Units","status":"COMPLETED","sponsor":"Corewell Health East","startDate":"2020-03-10","conditions":"Covid19","enrollment":704},{"nctId":"NCT00362947","phase":"PHASE3","title":"Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis","status":"COMPLETED","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2006-08","conditions":"Thrombophlebitis","enrollment":664},{"nctId":"NCT04671160","phase":"","title":"Impact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.","status":"UNKNOWN","sponsor":"Medical University of Gdansk","startDate":"2021-01-04","conditions":"Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis","enrollment":80},{"nctId":"NCT04508439","phase":"NA","title":"Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection","status":"UNKNOWN","sponsor":"Hospital Regional de Alta especialidad de Ixtapaluca","startDate":"2020-06-20","conditions":"Covid19, Pneumonia, Coagulation Disorder","enrollment":130},{"nctId":"NCT04361643","phase":"PHASE4","title":"Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial","status":"UNKNOWN","sponsor":"Hospital Universitario Getafe","startDate":"2020-10-27","conditions":"COVID-19","enrollment":120},{"nctId":"NCT03528967","phase":"PHASE4","title":"Enoxaparin in the Prevention of Placental Insufficiency in Pregnant Women","status":"COMPLETED","sponsor":"Les Laboratoires des Médicaments Stériles","startDate":"2013-10-23","conditions":"Placental Insufficiency, Enoxaparin","enrollment":89},{"nctId":"NCT04412746","phase":"","title":"Covid-19 and Diabetes in West of Algeria","status":"UNKNOWN","sponsor":"Laboratoire De Recherche Sur Le Diabete, Université de Tlemcen","startDate":"2020-04-01","conditions":"Coronavirus Infections, Diabetes Mellitus, Prevalence","enrollment":100},{"nctId":"NCT03963336","phase":"EARLY_PHASE1","title":"Quantitative D-dimer Level and Anticoagulant Therapy in Idiopathic Intracranial Hypertension","status":"COMPLETED","sponsor":"Fayoum University","startDate":"2017-07-22","conditions":"Idiopathic Intracranial Hypertension","enrollment":48},{"nctId":"NCT03805672","phase":"PHASE4","title":"Below Knee DVT Study","status":"TERMINATED","sponsor":"Oregon Health and Science University","startDate":"2014-09","conditions":"Deep Vein Thrombosis (DVT), Blood Clots","enrollment":4},{"nctId":"NCT02719418","phase":"","title":"Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses","status":"COMPLETED","sponsor":"Maisonneuve-Rosemont Hospital","startDate":"2016-02-01","conditions":"Renal Insufficiency, Chronic, Deep Venous Thrombosis, Protection Against","enrollment":28},{"nctId":"NCT02334007","phase":"PHASE1, PHASE2","title":"Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery","status":"COMPLETED","sponsor":"McMaster University","startDate":"2015-09","conditions":"Venous Thromboembolism, Lung Neoplasms, Pulmonary Embolism","enrollment":102},{"nctId":"NCT00585182","phase":"PHASE4","title":"Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT","status":"COMPLETED","sponsor":"University of Utah","startDate":"2007-01","conditions":"Obesity, Venous Thrombosis, Anticoagulants","enrollment":28},{"nctId":"NCT01518465","phase":"PHASE2","title":"Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma","status":"TERMINATED","sponsor":"University of Southern California","startDate":"2012-01-09","conditions":"Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma","enrollment":13},{"nctId":"NCT01149304","phase":"PHASE2","title":"Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity","status":"COMPLETED","sponsor":"University of Magdeburg","startDate":"2009-06","conditions":"Colorectal Cancer, Liver Metastases, Irradiation Damage","enrollment":22},{"nctId":"NCT01941602","phase":"","title":"A Comparative Study of Prophylactic Anticoagulation in Meningioma Surgery","status":"COMPLETED","sponsor":"St. Olavs Hospital","startDate":"2013-08","conditions":"Meningioma","enrollment":979},{"nctId":"NCT01274637","phase":"PHASE3","title":"PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2011-03","conditions":"Venous Thromboembolism, Postpartum","enrollment":62},{"nctId":"NCT03157843","phase":"","title":"Rate of Venous Thrombosis in Acutely Ill Patients Hospitalized in Internal Medicine Wards","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2015-02","conditions":"Venous Thromboembolism, Deep Venous Thrombosis","enrollment":1000},{"nctId":"NCT02260414","phase":"PHASE2","title":"Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2015-04-14","conditions":"Lymphoma, Multiple Myeloma","enrollment":19},{"nctId":"NCT00878826","phase":"PHASE2, PHASE3","title":"Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy.","status":"COMPLETED","sponsor":"Stanford University","startDate":"2009-05","conditions":"Venous Thrombosis","enrollment":11},{"nctId":"NCT02991950","phase":"PHASE3","title":"Weight Adjusted Low Molecular Weight Heparin in Recurrent Implantation Failure: a Randomized Open Labeled Trial","status":"TERMINATED","sponsor":"Istituto Clinico Humanitas","startDate":"2011-07","conditions":"Infertility, Low Molecular Weight Heparin","enrollment":271},{"nctId":"NCT01542762","phase":"NA","title":"Pot-Cast: Thrombosis Prophylaxis During Plaster Cast Lower Leg Immobilisation","status":"COMPLETED","sponsor":"Suzanne C. Cannegieter, MD PhD","startDate":"2012-03","conditions":"Deep Venous Thrombosis, Pulmonary Embolism","enrollment":1500},{"nctId":"NCT01542723","phase":"NA","title":"Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy","status":"COMPLETED","sponsor":"Suzanne C. Cannegieter, MD PhD","startDate":"2012-05","conditions":"Deep Venous Thrombosis, Pulmonary Embolism","enrollment":1500},{"nctId":"NCT00577096","phase":"NA","title":"Effects of Exercise in Combination With Epoetin Alfa","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2001-10","conditions":"Multiple Myeloma","enrollment":120},{"nctId":"NCT01419977","phase":"PHASE2","title":"Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo","status":"COMPLETED","sponsor":"Duke University","startDate":"2011-05","conditions":"Sickle Cell Disease, Vaso-occlusive Crisis","enrollment":34},{"nctId":"NCT00413088","phase":"PHASE1","title":"Study to Assess Bemiparin Pharmacokinetics in Renal Insufficiency and in the Elderly","status":"COMPLETED","sponsor":"Rovi Pharmaceuticals Laboratories","startDate":"2006-03","conditions":"Renal Insufficiency","enrollment":60},{"nctId":"NCT00097357","phase":"PHASE2, PHASE3","title":"BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2004-10","conditions":"Venous Thrombosis, Pulmonary Embolism","enrollment":1238}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":32,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Heparin - Prophylactic dosage","genericName":"Heparin - Prophylactic dosage","companyName":"University of Sao Paulo","companyId":"university-of-sao-paulo","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Heparin inhibits blood coagulation by potentiating antithrombin III, which inactivates thrombin and other clotting factors to prevent clot formation. Used for Prophylaxis of venous thromboembolism in surgical patients, Prophylaxis of deep vein thrombosis and pulmonary embolism in medical patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}